Invion is a clinical-stage life-sciences company that is leading the global clinical development of the Photosoft™ technology for the treatment of cancers. Invion has been appointed exclusive distributor and licensee in Australia and New Zealand of Photosoft™. The appointment has been made by technology licensor, The Cho Group, a Hong Kong based group that has funded and successfully commercialised a number of unique and advanced technologies. Via an R&D services agreement between the two entities, the research and clinical trials of Photosoft™ are funded by The Cho Group. Invion has an alliance with leading Australian medical research institute, Hudson Institute of Medical Research, for the Photosoft™ research program.
Looking for a particular Invion Limited employee's phone or email?
The Invion Limited annual revenue was $694000 in 2026.
Soumya Rai is the Program Director of Invion Limited.
5 people are employed at Invion Limited.
Invion Limited is based in South Melbourne, Victoria.
The NAICS codes for Invion Limited are [541, 54, 5417].
The SIC codes for Invion Limited are [87, 873].